Harrington Discovery Institute – Harrington Scholar and Alzheimer’s Drug Discovery Programs

February 26, 2020 by dld5dt@virginia.edu

Purpose and Background

Harrington Discovery Institute (HDI) invites you to submit LOIs for the 2021 Harrington Scholar-Innovator Award or the 2020 ADDF-Harrington Scholar Award. The first grant supports all disease areas and is designed to advance your promising drug discovery research towards the clinic. The second grant is designed to accelerate the translation of academic discoveries into medicines for treating, preventing, or curing patients with Alzheimer’s disease and related dementias. Of particular interest are targets related to proteostasis and neurovascular health. Researchers working on drug development programs that are relevant to, but not presently focused on, the Alzheimer’s field are encouraged to apply. In addition to grant funding, HDI provides guidance and oversight in all aspects of drug development, while taking no rights to intellectual property, which is retained by you/your institution.

Key Dates

Letters of Intent (LOI) due: April 10, 2020.
Full applications due May 22 for those invited to submit.

URLs for more information

Check out these short videos from Harrington Scholars.

To submit an online application, go to ADDF’s funding system and create an account.

Application questions? Contact grants@alzdiscovery.org or HDIQuestions@HarringtonDiscovery.org.

Scientific inquiries? Contact Meriel Owen, PhD, ADDF at mowen@alzdiscovery.org.


Filed Under: Funding Opportunities